Abstract
Within last 15 years, analyzing patterns of etiology and resistance in organisms causing neuroinfections, emergence of resistance has been observed in Slovakia in S. haemolyticus to teicoplanin (11%), Ps. aeruginosa and A. baumannii to meropenem (20%) and Candida spp. (non-albicans Candida spp.) to fluconazol (20%). There are no new antibiotics against carbapenem resistant Ps. aeruginosa and Acinetobacter baumannii.
MeSH terms
-
Anti-Infective Agents / therapeutic use*
-
Brain Diseases / drug therapy
-
Brain Diseases / microbiology
-
Candidiasis / drug therapy
-
Cross Infection / drug therapy*
-
Cross Infection / microbiology
-
Drug Resistance, Microbial*
-
Fluconazole / therapeutic use
-
Humans
-
Meningitis / drug therapy*
-
Meningitis / microbiology
-
Meropenem
-
Pseudomonas Infections / drug therapy
-
Staphylococcal Infections / drug therapy
-
Teicoplanin / therapeutic use
-
Thienamycins / therapeutic use
Substances
-
Anti-Infective Agents
-
Thienamycins
-
Teicoplanin
-
Fluconazole
-
Meropenem